Anlageziel

The Fund’s investment objective is to seek long-term capital appreciation (measured in USD). The fund primarily invests (at least 70% oftotal net assets) in equity securities, including depositary receipts (including American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs)), of companies located in the US that are principally engaged in the discovery, development, production, or distribution of products or services related to advances in healthcare. The investment process will emphasise a bottom up stock selection process seeking attractive investments on an individual company basis.